References
-
Beg, A. A. and Baltimore, D. : An essential role for NF-
$\kappa$ B in preventing TNF-$\alpha$ -induced cell death. Science 274, 782 (1996). https://doi.org/10.1126/science.274.5288.782 -
Alcamo, E., Mizqerd, J. P., Horwitz, B. H., Bronson, R., Beq, A. A., Scoot, M., Doerschuk, C. M., Hynes, R. O. and Baltimore, D. : Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-
${\kappa}B$ in leukocyte recruiment. J. Immunol. 167, 1592 (2001). https://doi.org/10.4049/jimmunol.167.3.1592 -
Kumar, A., Takada, Y., Boriek, A. M. and Aggarwal, B. B. : Nuclear factor-
$\kappa$ B: its role in health and disease. J. Mol. Med. 82, 434 (2004). - Kim, B. H., Reddy, A. M., Lee, K. H., Chung, E. Y., Cho, S. M., Lee, H., Min, K. R. and Kim, Y. : Inhibitory mechanism of chroman compound on LPS-induced nitric oxide production and nuclear factor-kappaB activation. Biochem. Biophys. Res. Commun. 325, 223 (2004). https://doi.org/10.1016/j.bbrc.2004.10.026
-
Kwak, J. H., Won, S. W., Kim, T. J., Roh, E., Kang, H. Y., Lee, H. W., Jung, J. K., Hwang, B. Y., Kim, Y., Cho, J. and Lee, H. : Synthesis of chroman-2-carboxylic acid N-(substituted) phenylamides and their inhibitory effect on nuclear factor-
$\kappa$ B (NF-$\kappa$ B) activation. Arch. Pharm. Res. 31, 133 (2008). https://doi.org/10.1007/s12272-001-1131-4 -
Yi, W., Han, S. B., Kim, Y., Jung, J. K. and Lee, H. : Synthesis and inhibitory activity on NF-
$\kappa$ B activation of chroman-2- carboxylic acid N-heteroarylamide derivatives. Yakhak Hoeji 56, 186 (2012). - Skehan, P., Storeng, R., Scudiero, D. A., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S. and Boyd, M. R. : New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82, 1107 (1990). https://doi.org/10.1093/jnci/82.13.1107